Tal Kafri

Title: Tal Kafri: Innovator in Retroviral Research

Introduction

Tal Kafri is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of virology, particularly in the development of retroviral packaging cell lines. His work has implications for gene therapy and the understanding of viral mechanisms.

Latest Patents

Tal Kafri holds a patent for a retroviral packaging cell line. The invention provides packaging cell lines and recombinant lentiviral or retroviral particles produced therefrom, particularly pseudotyped retroviral particles. The packaging cell lines are produced by inducibly expressing an envelope protein through specific methods. Additionally, the patent describes a screening assay for compounds that affect the integration of viral nucleic acid into target nucleic acid, identifying compounds based on their effect on viral integrase. He has 1 patent to his name.

Career Highlights

Tal Kafri is associated with the Salk Institute for Biological Studies, where he conducts his research. His work has been instrumental in advancing the understanding of retroviral mechanisms and their applications in therapeutic contexts.

Collaborations

Some of his notable coworkers include Inder M Verma and Frederic D Bushman. Their collaborative efforts contribute to the ongoing research in the field of virology.

Conclusion

Tal Kafri's innovative work in retroviral research highlights his role as a key inventor in the scientific community. His contributions continue to influence the field and pave the way for future advancements.